Karyopharm to participate at the jefferies healthcare conference

Newton, mass. , june 1, 2023 /prnewswire/ -- karyopharm therapeutics inc. (nasdaq: kpti), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the company's senior management team will participate at the jefferies healthcare conference in a fireside chat on thursday, june 8, 2023 at 10:00 a.m.
KPTI Ratings Summary
KPTI Quant Ranking